Xanthine oxidase inhibitor, allopurinol, prevented oxidative stress, fibrosis, and myocardial damage in isoproterenol induced aged rats

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Sagor, Md Abu Taher ^a   Tabassum, Nabila ^a   Potol, Md Abdullah ^a   Alam, Md Ashraful ^a  

^a NORTH SOUTH UNIVERSITY   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; MOBILE SECURITY; OXIDATIVE STRESS; PEPTIDES;

BIOCHEMICAL PARAMETERS; GLUTATHIONE CONCENTRATION; HISTOPATHOLOGICAL EXAMINATIONS; INFLAMMATORY CELLS; LIPID PEROXIDATION; MYOCARDIAL INFARCTION; OXIDATIVE STRESS MARKERS; REDUCED GLUTATHIONE;

RATS;

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALLOPURINOL; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; CATALASE; CREATINE KINASE MB; GLUTATHIONE; ISOPRENALINE; XANTHINE OXIDASE; ENZYME INHIBITOR; MALONALDEHYDE; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; HEART; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART PROTECTION; INFLAMMATORY CELL; ISOPROTERENOL-INDUCED MYOCARDIAL INFARCTION; KIDNEY MASS; KIDNEY STRUCTURE; LIPID PEROXIDATION; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; CARDIAC MUSCLE; DRUG EFFECTS; FIBROSIS; KIDNEY; LONG EVANS RAT; METABOLISM; PATHOLOGY;

RATTUS;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ALLOPURINOL; ANIMALS; ASPARTATE AMINOTRANSFERASES; BODY WEIGHT; CATALASE; CREATINE KINASE, MB FORM; ENZYME INHIBITORS; FIBROSIS; GLUTATHIONE; HEART; ISOPROTERENOL; KIDNEY; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MYOCARDIUM; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, LONG-EVANS; XANTHINE OXIDASE;

EID: 84934957179     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/478039     Document Type: Article

References (49)

1. E. Andres, A. Cordero, P. Magan et al., "Long-term mortality and hospital readmission after acute myocardial infarction: an eight-year follow-up study, " Revista Espanola de Cardiologia, vol. 65, no. 5, pp. 414-420, 2012
2. V. L. Roger, A. S. Go, D. M. Lloyd-Jones et al., "Heart disease and stroke statistics-2011 update: a report from the American Heart Association, " Circulation, vol. 123, no. 4, pp. e18-e209, 2011
3. P. R. Hansen, "Role of neutrophils in myocardial ischemia and reperfusion, " Circulation, vol. 91, no. 6, pp. 1872-1885, 1995
4. N. Rathore, S. John, M. Kale, and D. Bhatnagar, "Lipidperoxidation and antioxidant enzymes in isoproterenol induced oxidative stress in rat tissues, " Pharmacological Research, vol. 38, no. 4, pp. 297-303, 1998
5. C. Zaragoza, C. Gomez-Guerrero, J. L. Martin-Ventura et al., "Animal models of cardiovascular diseases, " Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 497841, 13 pages, 2011
6. L. Ou, W. Li, Y. Liu et al., "Animalmodels of cardiac disease and stem cell therapy, " Open Cardiovascular Medicine Journal, vol. 4, no. 2, pp. 231-239, 2010
7. A. J. Serra, M. H. H. Santos, D. S. Bocalini et al., "Exercise training inhibits inflammatory cytokines and more than prevents myocardial dysfunction in rats with sustained β-Adrenergic hyperactivity, " Journal of Physiology, vol. 588, no. 13, pp. 2431-2442, 2010
8. J. Zhang, A. Knapton, S. E. Lipshultz, J. L. Weaver, and E.H. Herman, "Isoproterenol-induced cardiotoxicity in sprague-dawley rats: correlation of reversible and irreversiblemyocardial injury with release of cardiac troponin T and roles of iNOS inmyocardial injury, " Toxicologic Pathology, vol. 36, no. 2, pp. 277-278, 2008
9. A. P. Davel, P. C. Brum, and L. V. Rossoni, "Isoproterenol induces vascular oxidative stress and endothelial dysfunction via a Gi-coupled 2-Adrenoceptor signaling pathway, " PLoS ONE, vol. 9, no. 3, Article ID e91877, 2014
10. M. Daz-M͡noz, M. A. Alvarez-Perez, L. Yãnnez et al., "Correlation between oxidative stress and alteration of intracellular calcium h and ling in isoproterenol-induced myocardial infarction, " Molecular and Cellular Biochemistry, vol. 289, no. 1-2, pp. 125-136, 2006
11. R. Rodrigo, M. Libuy, F. Feliu, and D. Hasson, "Oxidative stressrelated biomarkers in essential hypertension and ischemiareperfusion myocardial damage, " Disease Markers, vol. 35, no. 6, pp. 773-790, 2013
12. J.L. Zweier and M. A.H. Talukder, "The role of oxidants and free radicals in reperfusion injury, " Cardiovascular Research, vol. 70, no. 2, pp. 181-190, 2006
13. E. Takimoto and D.A. Kass, "Role of oxidative stress in cardiac hypertrophy and remodeling, " Hypertension, vol. 49, no. 2, pp. 241-248, 2007
14. T. P. Cappola, D. A. Kass, G. S. Nelson et al., "Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy, " Circulation, vol. 104, no. 20, pp. 2407-2411, 2001
15. N. Engberding, S. Spiekermann, A. Schaefer et al., "Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?" Circulation, vol. 110, no. 15, pp. 2175-2179, 2004
16. K. M. Minhas, R. M. Saraiva, K. H. Schuleri et al., "Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy, " Circulation Research, vol. 98, no. 2, pp. 271-279, 2006
17. W. G. Niehaus Jr. and B. Samuelsson, "Formation ofmalonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation, " European Journal of Biochemistry, vol. 6, no. 1, pp. 126-130, 1968
18. W. R. Tracey, J. Tse, and G. Carter, "Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors, " Journal of Pharmacology and Experimental Therapeutics, vol. 272, no. 3, pp. 1011-1015, 1995
19. V. Witko-Sarsat, M. Friedl and er, C. Capeillere-Bl and in et al., "Advanced oxidation protein products as a novel marker of oxidative stress in uremia, " Kidney International, vol. 49, no. 5, pp. 1304-1313, 1996
20. B. K. Tiwari, D. Kumar, A. B. Abidi, and S. I. Rizvi, "Efficacy of composite extract from leaves and fruits of medicinal plants used in traditional diabetic therapy against oxidative stress in alloxan-induced diabetic rats, " ISRN Pharmacology, vol. 2014, Article ID 608590, 7 pages, 2014
21. R. A. Khan, "Protective effects of Sonchus asper (L.)Hill, (Asteraceae) against CCl4-induced oxidative stress in the thyroid tissue of rats, " BMC Complementary and Alternative Medicine, vol. 12, no. 1, article 181, 2012
22. B. Chance and A.C. Maehly, "Assay of catalase and peroxidases, " Methods in Enzymology, vol. 11, pp. 764-775, 1955
23. D. J. Jollow, J. R. Mitchell, N. Zampaglione, and J. R. Gillette, "Bromobenzene induced liver necrosis. Protective role of glutathione and evidence for 3, 4 bromobenzene oxide as the hepatotoxic metabolite, " Pharmacology, vol. 11, no. 3, pp. 151-169, 1974
24. L. Vennila and K. V. Pugalendi, "Protective effect of sesamol againstmyocardial infarction caused by isoproterenol inWistar rats, " Redox Report, vol. 15, no. 1, pp. 36-42, 2010
25. V. Patel, A. Upaganlawar, R. Zalawadia, and R. Balaraman, "Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: a biochemical, electrocardiographic and histoarchitectural evaluation, " European Journal of Pharmacology, vol. 644, no. 1-3, pp. 160-168, 2010
26. P.K. Singal, R. E. Beamish, and N. S. Dhalla, "Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease, " Advances in Experimental Medicine and Biology, vol. 161, pp. 391-401, 1983
27. L. Liaudet, B. Calderari, and P. Pacher, "Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity, " Heart Failure Reviews, vol. 19, no. 6, pp. 815-824, 2014
28. P. Mladenka, R. Hrdina, Z. Bobrovova et al., "Cardiac biomarkers in a model of acute catecholamine cardiotoxicity, " Human and Experimental Toxicology, vol. 28, no. 10, pp. 631-640, 2009
29. C. E. Berry and J. M. Hare, "Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications, " Journal of Physiology, vol. 555, no. 3, pp. 589-606, 2004
30. N. Jia, P. Dong, Y. Ye, C. Qian, and Q. Dai, "Allopurinol attenuates oxidative stress and cardiac fibrosis in angiotensin IIinduced cardiac diastolic dysfunction, " Cardiovascular Therapeutics, vol. 30, no. 2, pp. 117-123, 2012
31. X. Gao, Y. Xu, B. Xuet al., "Allopurinol attenuates leftventricular dysfunction in rats with early stages of streptozotocin-induced diabetes, " Diabetes/Metabolism Research and Reviews, vol. 28, no. 5, pp. 409-417, 2012
32. H. Li, W. Yao, M. G. Irwin et al., "Adiponectin ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction by concomitantly activatingNrf2 and Brg1, " Free Radical Biology and Medicine, vol. 84, pp. 311-321, 2015
33. K. H. Sabeena Farvin, R. An and an, S. H. S. Kumar, K. S. Shiny, T. V. Sankar, and T. K. Thankappan, "Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats, " Pharmacological Research, vol. 50, no. 3, pp. 231-236, 2004
34. S. B. Rosalki, R. Roberts, H. A. Katus, E. Giannitsis, J. H. Ladenson, and F. S. Apple, "Cardiac biomarkers for detection of myocardial infarction: perspectives from past to present, " Clinical Chemistry, vol. 50, no. 11, pp. 2205-2213, 2004
35. S.-B. Wang, S. Tian, F. Yang, H.-G. Yang, X.-Y. Yang, and G.-H. Du, "Cardioprotective effect of salvianolic acid A on isoproterenol-inducedmyocardial infarction in rats, " European Journal of Pharmacology, vol. 615, no. 1-3, pp. 125-132, 2009
36. K. K. Mueen Ahmed, A. C. Rana, and V. K. Dixit, "Effect of Calotropis procera latex on isoproterenol induced myocardial infarction in albino rats, " Phytomedicine, vol. 11, no. 4, pp. 327-330, 2004
37. V. D. Pinto, G. J. S. Cutini, C. L. Sartrio, A. S. Paigel, D.V. Vassallo, and I. Stefanon, "Enhanced-Adrenergic response in rat papillarymuscle by inhibition of inducible nitric oxide synthase after myocardial infarction, " Acta Physiologica, vol. 190, no. 2, pp. 111-117, 2007
38. D. Li, Y. Qu, L. Tao et al., "Inhibition of iNOS protects the aging heart against-Adrenergic receptor stimulation-induced cardiac dysfunction and myocardial ischemic injury, " Journal of Surgical Research, vol. 131, no. 1, pp. 64-72, 2006
39. J. Wu, J. G. Hecker, and N. Chiamvimonvat, "Antioxidant enzyme gene transfer for ischemic diseases, " Advanced Drug Delivery Reviews, vol. 61, no. 4, pp. 351-363, 2009
40. S. K. Wattanapitayakul and J. A. Bauer, "Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implications, " Pharmacology and Therapeutics, vol. 89, no. 2, pp. 187-206, 2001
41. K. Karthikeyan, B. R. S. Bai, and S. N. Devaraj, "Cardioprotective effect of grape seed proanthocyanidins on isoproterenolinduced myocardial injury in rats, " International Journal of Cardiology, vol. 115, no. 3, pp. 326-333, 2007
42. M. Rajadurai and P. S. M. Prince, "Preventive effect of naringin on lipid peroxides and antioxidants in isoproterenol-induced cardiotoxicity inWistar rats: biochemical and histopathological evidences, " Toxicology, vol. 228, no. 2-3, pp. 259-268, 2006
43. D. Closa and E. Folch-Puy, "Oxygen free radicals and the systemic inflammatory response, " IUBMB Life, vol. 56, no. 4, pp. 185-191, 2004
44. T.M. Behr, X. Wang, N. Aiyar et al., "Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure, " Circulation, vol. 102, no. 11, pp. 1315-1322, 2000
45. A. Nicoletti, D. Heudes, C. M and et, N. Hinglais, J. Bariety, and J.-B. Michel, "Inflammatory cells and myocardial fibrosis: spatial and temporal distribution in renovascular hypertensive rats, " Cardiovascular Research, vol. 32, no. 6, pp. 1096-1107, 1996
46. N. Hinglais, D. Heudes, A. Nicoletti et al., "Colocalization of myocardial fibrosis and inflammatory cells in rats, " Laboratory Investigation, vol. 70, no. 2, pp. 286-294, 1994
47. A. Panizo, F. J. P. Mindall, M. F. Galindo, E. Cenarruzabeitia, M. Hern and ez, and J. Diez, "Are mast cells involved in hypertensive heart disease?" Journal of Hypertension, vol. 13, no. 10, pp. 1201-1208, 1995
48. N. Shiota, J. Rys, P. T. Kovanen, H. Ruskoaho, J. O. Kokkonen, and K. A. Lindstedt, "A role for cardiac mast cells in the pathogenesis of hypertensive heart disease, " Journal of Hypertension, vol. 21, no. 10, pp. 1935-1944, 2003
49. D. A. B. Kasal, M. F. Neves, W. Oigman, and C. A. M and arimde-Lacerda, "Allopurinol attenuates L-NAME induced cardiomyopathy comparable to blockade of angiotensin receptor, " Histology and Histopathology, vol. 23, no. 10, pp. 1241-1248, 2008